Treatment of Macro-Reentry Atrial Tachycardia with Very High-Power, Short-Duration, Temperature-Controlled Ablation of Anterior Line Using an Open-Irrigated Ablation Catheter with Microelectrodes
Abstract:Patient: Male, 74-year-old
Final Diagnosis: Atrial fibrillation
Symptoms: Tachycardia
Medication:—
Clinical Procedure: —
Specialty: Cardiology
Objective:
Unusual clinical course
Background:
Treatment of atrial fibrillation and atrial tachycardia (AT) with catheter ablation results in high rates of success with the procedure and on long-term follow-up. A novel ablation catheter with a very high-power… Show more
“…In patients with AT a high-density activation mapping utilizing a 3D electroanatomical mapping system (Carto or EnsiteX) of the LA was assessed and the AT was treated according to the institutional standards. [13] The ablation strategies during repeat procedures are mentioned in Table 3 . Briefly, perimitral AT was detected in 6 patients (vHP-SD) and 3 patients (control) and was treated by performing an anterior line due to scar formation at the anterior aspect of the LA.…”
“…In patients with AT a high-density activation mapping utilizing a 3D electroanatomical mapping system (Carto or EnsiteX) of the LA was assessed and the AT was treated according to the institutional standards. [13] The ablation strategies during repeat procedures are mentioned in Table 3 . Briefly, perimitral AT was detected in 6 patients (vHP-SD) and 3 patients (control) and was treated by performing an anterior line due to scar formation at the anterior aspect of the LA.…”
“…Although the QDOT MICRO™ Catheter was designed for atrial procedures data on the treatment of atrial tachycardia is limited to only one published case report 39 …”
Section: Ablation Of Atrial Tachycardia By the Qdot Micro™ Cathetermentioning
confidence: 99%
“…Here complete CTI block using vHPSD ablation was achieved in all 15 patients. A median of 23 (20,39) RF applications over a median RF ablation time of 92 (78, 154) s were applied and no periprocedural complications, no charring, and no steam pops were observed. 49 The preliminary data show that vHPSD ablation might represent an effective and safe strategy to achieve bidirectional CTI block for the treatment of typical AFL.…”
Section: Qdot Micro™ Catheter For Cavotricuspid Isthmus (Cti) Ablationmentioning
confidence: 99%
“…Although the QDOT MICRO™ Catheter was designed for atrial procedures data on the treatment of atrial tachycardia is limited to only one published case report. 39 Here a patient with perimitral atrial tachycardia with a critical isthmus on the anterior wall was treated by the QDOT MICRO™ Catheter utilizing QMODE+ only. An ablation of an anterior line was performed.…”
Section: Ablation Of Atrial Tachycardia By the Qdot Micro™ Cathetermentioning
confidence: 99%
“…The combination of microelectrodes and vHPSD ablation seems to be an interesting option for mapping and ablation of atrial tachycardias (Figure 4). 39 Please also see Supporting Information: Video 3 for perimitral AT ablation by vHPSD only.…”
Section: Ablation Of Atrial Tachycardia By the Qdot Micro™ Cathetermentioning
The QDOT MICRO™ Catheter is a novel open‐irrigated contact force‐sensing radiofrequency ablation catheter. It offers very high‐power short‐duration (vHPSD) ablation with 90 W for 4 s to improve safety and efficacy of catheter ablation procedures. Although the QDOT MICRO™ Catheter was mainly designed for pulmonary vein isolation (PVI) its versatility to treat atrial fibrillation (AF) and other types of arrhythmias was recently evaluated by the FAST and FURIOUS study series and other studies and will be presented in this article. Available study and registry data as well as case reports concerning utilization of the QDOT MICRO™ Catheter for the treatment of cardiac arrhythmias including AF, focal and macroreentry atrial tachycardia, typical atrial flutter by cavotricuspid isthmus block, premature ventricular contractions, and accessory pathways were reviewed and summarized. In summary, the QDOT MICRO™ Catheter showed safety and efficacy for PVI and is able to treat also other types of arrhythmias as is was recently evaluated by case reports and the FAST and FURIOUS studies.
Catheter ablation has become a cornerstone in atrial fibrillation (AF) therapy,
improving freedom from all-atrial arrhythmias, as well as outperforming
antiarrhythmic drugs in alleviating AF-related symptoms, reducing
hospitalizations, and enhancing quality of life. Nevertheless, the success rate
of traditional radiofrequency ablation (RFA) methods remains less than ideal. To
address these issues, refinement in RFA strategies has been developed to improve
efficacy and laboratory efficiency during pulmonary vein isolation (PVI).
High-power short-duration (HPSD) RFA has emerged as a safe strategy to reduce the
time required to produce durable lesions. This article reviews critical aspects
of HPSD ablation in the management of both paroxysmal and persistent AF,
covering aspects such as effectiveness, safety, procedural intricacies, and the underlying biophysics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.